Pharming (PHAR) Profit After Tax (QoQ) (2020 - 2026)
Pharming (PHAR) Profit After Tax (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Pharming | 8.96 Bn | 8.91 Bn | 65.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -143.18% |
| Dec 31, 2025 | 57,597,692.18% |
| Sep 30, 2025 | -100.00% |
| Jun 30, 2025 | 81.58% |
| Mar 31, 2025 | 160.28% |
| Dec 31, 2024 | -439.70% |
| Sep 30, 2024 | 106.74% |
| Jun 30, 2024 | -437.62% |
| Mar 31, 2024 | 69.01% |
| Dec 31, 2023 | -527.81% |
| Sep 30, 2023 | 120.08% |
| Jun 30, 2023 | 13.47% |
| Mar 31, 2023 | -232.86% |
| Dec 31, 2022 | 171.17% |
| Sep 30, 2022 | -188.83% |
| Jun 30, 2022 | 499.64% |
| Mar 31, 2022 | -75.00% |
| Dec 31, 2021 | 4,589.25% |
| Sep 30, 2021 | -105.48% |
| Jun 30, 2021 | -31.15% |